Efficacy and tolerability of once-daily 5mg desloratadine, an H1-receptor antagonist, in patients with seasonal allergic rhinitis: Assessment during the spring and fall allergy seasons

Clinical Drug Investigation

Volumn 21, Issue 1, 2001, Pages 25-32

  Meltzer, E O ^a   Prenner, B M ^b   Nayak, A ^c  

^a ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^b Allergy Associates Medical Group Inc   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESLORATADINE; HISTAMINE H1 RECEPTOR ANTAGONIST;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHARYNGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; SEASON; SEDATION; SOMNOLENCE; SYMPTOM; TREATMENT OUTCOME; UNITED STATES; XEROSTOMIA;

EID: 0035126404     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200121010-00004     Document Type: Article

References (16)

1. Allergic rhinitis: Epidemiology and natural history
2. Treating allergic rhinitis with second-generation antihistamines
3. Induction and regulation of the IgE response
4. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist: 1st communication: Receptor selectivity, antihistaminic activity, and antiallergenic effects
5. A pharmacokinetic profile of desloratadine in healthy adults including elderly subjects
6. The oral bioavailability of desloratadine is unaffected by food
7. Lack of interaction between desloratadine and erythromycin
8. Desloratadine has no electrocardiographic or pharmacodynamic interactions with ketoconazole
9. Lack of electrocardiographic effects of multiple high doses of desloratadine
10. Evaluation and management of allergic rhinitis
11. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: Effects after controlled ragweed pollen challenge in an environmental exposure unit
12. Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis
13. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis
14. Effectiveness and safety of fexofenadine, a new nonsedating H1-receptor antagonist, in the treatment of fall allergies
15. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis